Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.765 CHF | -2.35% | +5.77% | +0.92% |
Apr. 25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.92% | 125M | |
+14.89% | 77.63B | |
+12.05% | 8.78B | |
+57.26% | 4.93B | |
-16.24% | 4.79B | |
+1.45% | 3.8B | |
+21.86% | 2.46B | |
-26.19% | 2.2B | |
+16.04% | 2.1B | |
-37.26% | 1.96B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Pharmaceuticals : Completes First Six-Month Period in Mid-Stage Trial For Duchenne Muscular Dystrophy Drug